These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31557960)

  • 1. Potential Role of MSC/Cancer Cell Fusion and EMT for Breast Cancer Stem Cell Formation.
    Hass R; von der Ohe J; Ungefroren H
    Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31557960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness.
    Hass R; von der Ohe J; Ungefroren H
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced metastatic capacity of breast cancer cells after interaction and hybrid formation with mesenchymal stroma/stem cells (MSC).
    Melzer C; von der Ohe J; Hass R
    Cell Commun Signal; 2018 Jan; 16(1):2. PubMed ID: 29329589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance.
    Mallini P; Lennard T; Kirby J; Meeson A
    Cancer Treat Rev; 2014 Apr; 40(3):341-8. PubMed ID: 24090504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Fusion of Normal and Neoplastic Breast Epithelial Cells with Human Mesenchymal Stroma/Stem Cells Partially Involves Tumor Necrosis Factor Receptor Signaling.
    Melzer C; von der Ohe J; Hass R
    Stem Cells; 2018 Jul; 36(7):977-989. PubMed ID: 29569804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Tumor Plasticity after Different Cancer Cell Fusions with MSC.
    Melzer C; Ohe JV; Hass R
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of MSC with tumor cells.
    Melzer C; Yang Y; Hass R
    Cell Commun Signal; 2016 Sep; 14(1):20. PubMed ID: 27608835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concise Review: Crosstalk of Mesenchymal Stroma/Stem-Like Cells with Cancer Cells Provides Therapeutic Potential.
    Melzer C; von der Ohe J; Hass R
    Stem Cells; 2018 Jul; 36(7):951-968. PubMed ID: 29603861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells.
    Melzer C; von der Ohe J; Lehnert H; Ungefroren H; Hass R
    Mol Cancer; 2017 Feb; 16(1):28. PubMed ID: 28148265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion with mesenchymal stem cells differentially affects tumorigenic and metastatic abilities of lung cancer cells.
    Zhang LN; Kong CF; Zhao D; Cong XL; Wang SS; Ma L; Huang YH
    J Cell Physiol; 2019 Apr; 234(4):3570-3582. PubMed ID: 30417342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity and Plasticity of Breast Cancer Stem Cells.
    Sousa B; Ribeiro AS; Paredes J
    Adv Exp Med Biol; 2019; 1139():83-103. PubMed ID: 31134496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.
    Mandal S; Arfuso F; Sethi G; Dharmarajan A; Warrier S
    Int J Biochem Cell Biol; 2019 May; 110():59-69. PubMed ID: 30735730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling.
    Bocci F; Jolly MK; George JT; Levine H; Onuchic JN
    Oncotarget; 2018 Jul; 9(52):29906-29920. PubMed ID: 30042822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells.
    Marcucci F; Ghezzi P; Rumio C
    Mol Cancer; 2017 Jan; 16(1):3. PubMed ID: 28137290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of MSC in the Tumor Microenvironment.
    Hass R
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMT in breast cancer stem cell generation.
    Ansieau S
    Cancer Lett; 2013 Sep; 338(1):63-8. PubMed ID: 22634497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
    Jayachandran A; Dhungel B; Steel JC
    J Hematol Oncol; 2016 Aug; 9(1):74. PubMed ID: 27578206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing the BMP signaling pathway to control the formation of cancer stem cells by effects on epithelial-to-mesenchymal transition.
    Bosukonda A; Carlson WD
    Biochem Soc Trans; 2017 Feb; 45(1):223-228. PubMed ID: 28202676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.